Study Into Antinociceptive Activity of a New Molecule from the Class of Hexaazaizowurzitane

In this work, we studied the pharmacological activity of a newly-synthesized compound 4-(3,4- dibromothiophenylcarbonyl)-10-(2-ethoxyacetyl)-2,6,8,12-tetraacetyl-2,4,6,8,10,12-hexaazatetracyclo[5,5,0,03,11,05,9]dodecane (M3) using somatogenic pain models of various genesis (thermal and visceral pain, mechanical compression of a paw). The compound showed a high antinociceptive efficacy, comparable to or exceeding that of tramadol. It was shown that the new molecule from the class of hexaazaisowurtzitane effectively blocks nociceptive reactions at the supraspinal and peripheral levels of pain sensitivity organization. The results obtained confirm the possibility of creating new pharmacologically active molecules based on the high-energy substance of hexaazaisowurtzitane, which is a priority in domestic pharmaceutical production.

1. Voronina T.A., Guzevatykh L.S. Metodicheskie rekomendatsii po izucheniyu anal’geticheskoy aktivnosti lekarstvennykh sredstv [Guidelines for the study of analgesic activity of drugs]. Ruk-vo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv [Guidelines for conducting preclinical studies of drugs]. Ed. A.N. Mironov. Part 1. Moscow; 2012:199– 207. (In Russian).

2. Krylova S.G., Povetyeva T.N., Lopatina K.A., Nesterova Yu.V., Zueva E.P., Afanasyeva O.G., Kiseleva E.A., Kulpin P.V., Suslov N.I., Kulagina D.A., Sysolyatin S.V., Zhdanov V.V. Risk razvitiya lekarstvennoy zavisimosti pri primenenii novogo anal’getika na osnove proizvodnogo geksaazaizovyurtsitana (eksperimental’noe issledovanie) [Risk of developing drug abuse in administration of a new hexaazaisowurtzitane derivative-based analgesic (experimental study)]. Bulletin of Siberian Medicine. 2022;21(1):54– 62. (In Russian). DOI: 10.20538/1682-0363-2022-1- 54-62.

3. Lakin G.F. Biometrics. Textbook for biological special universities. 4th ed., revised. Moscow: Vysshaya shkola Publ., 1990. (In Russian).

4. Lemeshko B.Yu., Lemeshko S.B. Ob ustoychivosti i moshchnosti kriteriev proverki odnorodnosti srednikh [On the stability and power of criteria for checking the homogeneity of means]. Izmeritel’naya tekhnika [Measuring technology]. 2008;9:23–28. (In Russian).

5. Palekhov A.V., Vvedenskaya E.S. Opioidnye anal’getiki, problemy segodnyashnego dnya i poisk putey ikh resheniya [Opioid analgesics, problems of today and the search for ways to solve them]. Rossiyskiy zhurnal boli [Russian Journal of Pain]. 2017;3–4(54):89–94. (In Russian).

6. Sosnov A.V., Sadovnikov S.V., Semchenko F.M., Rufanov K.A., Tokhmakhchi V.N., Sosnova A.A., Tyurin I.A Sil’nodeystvuyushchie nenarkoticheskie anal’getiki kak napravlenie razvitiya farmatsevtiki [Potent non-narcoticanalgesics as a direction of pharmaceutical development]. Razrabotka i registratsiya lekarstvennykh sredstv [Drug development & registration]. 2016;1:196–206. (In Russian).

7. Aguero S., Megy S., Eremina V.V., Kalashnikov A.I., Krylova S.G., Kulagina D.A., Lopatina K.A., Fournier M., Povet’eva T.N., Vorozhtsov A.B., Sysolyatin S.V., Zhdanov V.V., Terreux R. Discovery of a novel non-narcotic analgesic derived from the CL-20 explosive: Synthesis, pharmacology, and target identification of thiowurtzine, a potent inhibitor of the opioid receptors and the ion channels. ACS Omega. 2021;6(23):15400–15411. DOI: 10.1021/acsomega.1c01786.

8. Barrot M. Tests and models of nociception and pain in rodents. Neuroscience. 2012;211:39–50. DOI: 10.1016/j.neuroscience.2011.12.041.

9. Katzung B.G. Basic & clinical pharmacology, 14th ed. McGraw-Hill Education, 2018:409–438.

10. Krylova S.G., Lopatina K.A., Nesterova Yu.V., Povet’eva T.N., Kul’pin P.V., Afanas’eva O.G., Kulagina D.A., Safonova E.A., Zueva E.P., Suslov N.I., Sysolyatin S.V. Some aspects of investigation of the central mechanism of antinociceptive effect of a new analgetic from the hexaazaisowurtzitane group. Bull. Exp. Biol. Med. 2021;170(6):752–758. DOI: 10.1007/s10517-021-05148-w.

11. Nijs J., George S.Z., Clauw D.J., Fernández-de-lasPeñas C., Kosek E., Ickmans K., Fernández-Carnero J., Polli A., Kapreli E., Huysmans E., Cuesta-Vargas A.I., Mani R., Lundberg M., Leysen L., Rice D., Sterling M., Curatolo M. Central sensitisation in chronic pain conditions: Latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3(5):e383– e392. DOI: 10.1016/S2665-9913(21)00032-1.

12. Sysolyatin S.V., Lobanova A.A., Chernikova Yu.T., Sakovich G.V. Methods of synthesis and properties of hexanitrohexaazaisowurtzitane. Russ. Chem. Rev. 2005;74(8):757–764. DOI: 10.1070/ RC2005v074n08ABEH001179.

13. Turner P.V., Turner D.S., Pang J.L., Lofgren A. Review of pain assessment methods in laboratory rodents. Comp. Med. 2019;69(6):451–467. DOI: 10.30802/ AALAS-CM-19-000042.

14. Yam M.F., Loh Y.C., Tan C.S., Khadijah Adam S., Abdul Manan N., Basir R. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int. J. Mol. Sci. 2018;19(8):2164. DOI: 10.3390/ijms19082164.